全人源糖基优化重组FSH(follitropin epsilon)的随机对照II期临床试验
该研究为随机、评估者盲法、对照、六臂II期试验,纳入247名18-37岁接受IVF的女性,比较不同剂量follitropin epsilon与follitropin alfa的卵巢刺激效果。主要结局(直径≥12mm卵泡数)未显示任一follitropin epsilon剂量优于对照;follitropin epsilon 75 IU与follitropin alfa 150 IU结果最相似,前者可在III期试验中进一步验证。
要点
- follitropin epsilon 75 IU每日与follitropin alfa 150 IU每日的卵巢反应相似。
- 主要结局卵泡数未见follitropin epsilon各剂量优于对照。
- follitropin epsilon 112.5 IU在激素水平和获卵数上强于follitropin alfa 150 IU。
核心结论
- follitropin epsilon 75 IU每日的卵巢反应与标准剂量follitropin alfa 150 IU每日相似,该剂量可进入III期试验。
研究设计与样本
- 随机、评估者盲法、对照、六臂II期临床试验,纳入247名18-37岁接受IVF的女性。
- 在长方案GnRH激动剂方案下,比较follitropin epsilon 52.5、75、112.5、150 IU每日或150 IU隔日与follitropin alfa 150 IU每日。
- 试验在 two European countries 的八家生殖诊所进行。
主要发现
- 主要结局(直径≥12mm卵泡数)未显示任何follitropin epsilon剂量优于对照。
- follitropin epsilon 75 IU产生的卵巢反应与follitropin alfa 150 IU最相似。
- follitropin epsilon 112.5 IU在雌二醇、抑制素B、孕酮等激素浓度及获卵数等次要结局上强于follitropin alfa 150 IU。
临床怎么用
- follitropin epsilon 75 IU每日可作为与follitropin alfa 150 IU每日等效的候选剂量用于卵巢刺激。
- 该剂量需在III期临床试验中进一步验证后方可常规推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: The study aimed to determine the standard treatment dose of follitropin epsilon for ovarian stimulation in the context of IVF treatment. DESIGN: A total of 247 women aged 18-37 years were treated with either 52.5, 75, 112.5 or 150 IU follitropin epsilon daily, or 150 IU every other day, or 150 IU follitropin alfa daily in a long gonadotrophin-releasing hormone agonist protocol. The study was performed as a randomized, assessor-blinded, comparator-controlled, six-armed phase II trial in eight fertility clinics in two European countries. RESULTS: The primary results were as follow. First, none of the doses of follitropin epsilon showed superiority for the main outcome measure, i.e. number of follicles ≥12 mm in size. Follitropin epsilon 75 IU produced results most similar to those of follitropin alfa 150 IU. In terms of secondary results, stronger effects of follitropin epsilon 112.5 IU compared with follitropin alfa 150 IU were seen for secondary outcome measures such as hormone concentrations (oestradiol, inhibin B and progesterone) and oocyte number. CONCLUSIONS: Follitropin epsilon 75 IU daily results in a similar ovarian response to a standard dose of 150 IU follitropin alfa. This dose could be tested in a phase III trial.
引用
- Griesinger G, Dietrich B, Stöckl L, et al. Fully human glyco-optimized recombinant FSH (follitropin epsilon) - a randomized, comparator-controlled phase II clinical trial. Reprod Biomed Online. 2019. PMID: 31982355. doi:10.1016/j.rbmo.2019.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。